Genesis Molecular AI launches Ruby potency model, up to 1000x faster, open-sources training data
edunov · x · 2026-11-21
Genesis Molecular AI unveiled Ruby, an AI model for predicting drug candidate potency, building on last year's 3D binding model Pearl without needing full 3D structures — hence its speed. With pharma partner Incyte, Ruby showed a step-change on real drug programs and runs 40x–1000x+ faster per compound at its fastest setting, leading all published models found on public benchmarks including free-energy methods. Genesis is also open-sourcing GenesisPotency-2026, part of its audited training data, free for academic and commercial use.
Related event: Genesis Releases Open-Source Drug Potency Model Ruby(2 posts)→
More from Research
- Claude-generated timeline reveals the 20-step path of the Riemann proof attempt — Kyrannio · 2026-11-21
- The 250,000-page Riemann proof claim: when computational verification outpaces human comprehension — SydSteyerhart · 2026-11-21
- 'All AI can do is plagiarize': model caught regurgitating a proof straight from The Book — moyix · 2026-11-21
- Experts gave AI 10% odds of cracking a Millennium Prize Problem by 2027 — two now claimed — theimposingshadow · 2026-11-21
- Dario says Anthropic found a new gene-editing mechanism; critics cite Feng Zhang's leaner record — max_paperclips · 2026-11-21
- GPTZero scans millions of citations: hallucination rates flat or rising at CVPR, ICLR, EMNLP — HanchungLee · 2026-11-21